51. Preziosi R, Sarli G, Benazzi C, et al. Detection of proliferating cell nuclear antigen (PCNA) in canine and feline mammary
tumours. J Comp Pathol 1995;113:301-313.
52. Millanta F, Lazzeri G, Mazzei M, et al. MIB-1 labeling index in feline dysplastic and neoplastic mammary lesions and its
relationship with postsurgical prognosis. Vet Pathol 2002;39:120-126.
53. Dias Pereira P, Carvalheira J, Gartner F. Cell proliferation in feline normal, hyperplastic and neoplastic mammary tissue—an
immunohistochemical study. Vet J 2004;168:180-185.
54. Dias Pereira P, Gartner F. Expression of E-cadherin in normal, hyperplastic and neoplastic feline mammary tissue. Vet Rec 2003;153:297-302.
55. Madewell BR, Gandour-Edwards R, Edwards BF, et al. Topographic distribution of bcl-2 protein in feline tissues in health
and neoplasia. Vet Pathol 1999;36:565-573.
56. Murakami Y, Tateyama S, Rungsipipat A, et al. Immunohistochemical analysis of cyclin A, cyclin D1 and P53 in mammary tumors,
squamous cell carcinomas and basal cell tumors of dogs and cats. J Vet Med Sci 2000;62:743-750.
57. Nasir L, Krasner H, Argyle DJ, et al. Immunocytochemical analysis of the tumour suppressor protein (p53) in feline neoplasia.
Cancer Lett 2000;155:1-7.
58. Mayr B, Blauensteiner J, Edlinger A, et al. Presence of p53 mutations in feline neoplasms. Res Vet Sci 2000;68:63-70.
|
Featuring Information from:
